Fetal Death clinical trials
The registry lists 33 studies for Fetal Death across more than 10 countries. 8 are recruiting or about to start. 11 of them are mainly about Fetal Death (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-14. Counting its narrower condition Stillbirth too: 140 studies, 36 open.
Get an email when these change. Save the Fetal Death studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University of Chicago (2) · Stanford University (2) · Washington University School of Medicine (1) · Emergent BioSolutions (1) · Montefiore Medical Center (1) · National Institute of Perinatology (1) · Jinling Hospital, China (1) · The Hospital for Sick Children (1)
What is being tested here
Drugs under test in Fetal Death studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Melatonin | 1 | 1 | 1 |
| Mifepristone | 0 | 1 | 4 |
| Misoprostol | 0 | 0 | 2 |
| Cabergoline | 0 | 0 | 1 |
| Enoxaparin | 0 | 0 | 1 |
| Dinoprostone | 0 | 0 | 1 |
| Dexmedetomidine | 0 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2, phase 3 first
- Apr 2027Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction · Phase 3 · Monash University
- Sep 2027Feasibility Trial of the Womb Watch Smartphone App To Assess Fetal Movements · Kenneth Moise MD
Who these studies take
Of the 7 Fetal Death studies recruiting now, 3 (43%) set no upper age limit and 4 (57%) stop at 75 or younger. 2 (29%) take children under 18. 6 (86%) are for women only and 0 (0%) for men only; 3 (43%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 7 (100%) | 1 (14%) |
| 30 | 7 (100%) | 1 (14%) |
| 40 | 7 (100%) | 1 (14%) |
| 50 | 5 (71%) | 0 (0%) |
| 65 | 3 (43%) | 0 (0%) |
| 75 | 3 (43%) | 0 (0%) |
| 85 | 3 (43%) | 0 (0%) |
Across all 33 studies, recruiting or not: 36% stop at 75 or younger and 36% at 65; 30% take children; 82% are for women only and 0% for men only; 42% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 33 of 33. search them.
- Feasibility Trial of the Womb Watch Smartphone App To Assess Fetal MovementsRecruitingNCT076261121 country
- Determinants of Repeated Spontaneous Miscarriages and Unexplained Fetal DeathsRecruitingNCT04207814Not applicable1 country
- Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal DemiseRecruitingNCT037759541 country
- Mothers Working to Prevent Early Stillbirth Study 20-28RecruitingNCT060052721 country
- Investigating the Structured Use of Ultrasound Scanning for Fetal GrowthRecruitingNCT036621781 country
- AI-POCUS for Maternal and Neonatal Health in EthiopiaNot yet recruitingNCT07171086Phase 41 country
- Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth RestrictionRecruitingNCT05651347Phase 32 countries
- Diamine Oxidase and Adverse Pregnancy OutcomesRecruitingNCT062813661 country
- Parents' Experience of Child Loss During Pregnancy or BirthCompletedNCT067716611 country
- Perioperative Dexmedetomidine to Reduce Post-procedure Grief Following Second-trimester Dilation and EvacuationWithdrawnNCT07537894Phase 2/31 country
- Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled TrialCompletedNCT05322252Phase 41 country
- Free DNA and Nucleosome Concentrations in Pathological PregnanciesCompletedNCT017368261 country
- Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy LossCompletedNCT06029673Phase 21 country
- IntraCERvical Balloon Catheter in the Setting of Induction of Labor for Fetal Loss or AbortionWithdrawnNCT06456164Not applicable
- Intervention to Prevent Mental Health Disorders of Women and Their Partners Who Experienced Pregnancy LossActive, not recruitingNCT06340555Not applicable1 country
- BioThrax® (Anthrax) Vaccine in Pregnancy RegistryCompletedNCT016533921 country
- Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.CompletedNCT034553871 country
- Mifepristone Induction for Fetal DemiseTerminatedNCT02620904Phase 41 country
- A Feasibility Study of Virtopsy With Tissue Sampling in Besancon University HospitalCompletedNCT038779001 country
- Environmental Factors and Embryonic Development ProjectStatus unknownNCT041825031 country
- Antenatal Palliative CareCompletedNCT037958571 country
- Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal DeathTerminatedNCT02633761Phase 32 countries
- University Hospital Advanced Age Pregnant CohortStatus unknownNCT032207501 country
- Comparative Evaluation of IRM and Autopsy in the Evaluation of Intra Uterine Fetal DeathTerminatedNCT02148055Not applicable1 country
- Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)TerminatedNCT001493572 countries
- Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in PregnancyCompletedNCT007215911 country
- Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy OutcomeCompletedNCT01068795Not applicable1 country
- Misoprostol for Second Trimester Pregnancy TerminationCompletedNCT02669420Phase 2
- Mifepristone and Misoprostol for Fetal DemiseCompletedNCT00177372Phase 41 country
- Medical Management of Late Intrauterine Death.CompletedNCT02488642Phase 4
- Comparison of Abnormal Cortical Development in Brain Malformations on Postmortem Imaging With AutopsyWithdrawnNCT006865301 country
- MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy FailureTerminatedNCT00468299Not applicable1 country
- Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term PregnanciesStatus unknownNCT00432588Phase 1/21 country